Citing progress, FDA OKs Siam Bioscience / WRITER: APINYA WIPATAYOTIN

.

AstraZeneca’s plan to produce its Covid-19 vaccine in Thailand has made significant progress and the first batch of vaccines will be ready for delivery to the government by June.

The Food and Drug Administration (FDA) has approved Siam Bioscience as a manufacturing facility for AstraZeneca’s Covid-19 vaccine. The company, together with Siam Bioscience, has been working tirelessly to ensure that the facility is on track to safely deliver supply to support the national vaccination campaign. The collaboration with the Thai government and the FDA has facilitated the swift but careful progress with the manufacturing plant over the past few months, according to a statement issued by AstraZeneca (Thailand) Ltd on Wednesday.

.

READ MORE:  https://aseanews.net/2021/04/29/headline-bangkok-thailand-local-astrazeneca-jab-ready-by-june/

.

The coronavirus COVID-19 is affecting 218 countries and territories around the world and 2 international conveyances.

.

COVID-19 infection crosses 150.13 million globally as deaths cross 3.16 million.

.

Here is the GLOBAL status as of Friday, 7am, April 29, 2021

.

The update-4.29.2021 Sick Earth Plague Day 519

 (1 Year, 4 Months, 29 Days)

Coronavirus Covid-19

Cases Globally: 150,131,288;

Deaths: 3,161,594:

Recovered: 127,580,514

.

Thailand

Reported +2,012 new cases, total at 61,699, +15 new deaths, total deaths stands at 178.

.

Ads by: Memento Maxima Digital Marketing
@[email protected]
SPACE RESERVE FOR  ADVERTISEMENT

 

.

Ads by: Memento Maxima Digital Marketing
@[email protected]
SPACE RESERVE FOR  ADVERTISEMENT

4.28.2021

.

Ads by: Memento Maxima Digital Marketing
@[email protected]
SPACE RESERVE FOR  ADVERTISEMENT

 

.Ads by: Memento Maxima Digital Marketing
@[email protected]
SPACE RESERVE FOR  ADVERTISEMENT

‘

 

.

Ads by: Memento Maxima Digital Marketing
@[email protected]
SPACE RESERVE FOR  ADVERTISEMENT

.

It's only fair to share...